MDxHealth SA — Form SCHEDULE 13D
Filed August 14, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D
— Neutral
significance 28/100
What the filing says
Bleichroeder LP and Bleichroeder Holdings LLC executed a joint filing agreement dated August 14, 2026, to file a Schedule 13D together regarding ordinary shares of MDxHealth SA. The agreement allows them to file amendments on behalf of each other under Rule 13d-1(k) of the Securities Exchange Act of 1934. No specific share count, dollar amounts, or current ownership percentage are disclosed in this document.
Why this rating
Joint filing agreement is procedural; actual 13D holding details (trigger, size, intent) not yet disclosed. Insufficient context to assess materiality.
See more from August 14, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.